查看購物車
  • Simplified Chinese
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
1317873

發作性睡病治療藥物市場：按藥物類別、發作性睡病類型、配銷通路- 全球預測 2023-2030

Narcolepsy Treatment Market by Drug Class, Narcolepsy Type, Distribution Channel - Cumulative Impact of COVID-19, Russia Ukraine Conflict, and High Inflation - Global Forecast 2023-2030
出版日期: | 出版商: 360iResearch | 英文 195 Pages | 商品交期: 最快1-2個工作天內

價格

※ 本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

全球發作性睡病治療藥物市場預計將以 13.43%的年複合成長率大幅成長，到 2023 年達到 38.6874 億美元，預計到 2030 年將達到驚人的 93.6151 億美元。

FPNV定位矩陣

FPNV定位矩陣對於評估全球發作性睡病治療藥物市場至關重要。透過檢驗業務策略和產品滿意度的關鍵指標，我們對供應商進行全面評估，使您能夠根據您的特定需求做出明智的資訊。這種進階分析將供應商分為四個像限，並取得了不同程度的成功：前沿 (F)、探路者 (P)、利基 (N) 和重要 (V)。

市佔率分析

市場佔有率分析可以深入了解供應商在特定市場領域的當前地位。比較供應商對總收入、基本客群和其他關鍵指標的貢獻，可以幫助公司更好地了解他們在爭奪市場佔有率時的表現以及面臨的情況。該分析還揭示了特定行業的競爭程度、累積和合併的優勢以及研究基準年的合併特徵。

本報告提供了以下幾點見解：

1. 市場滲透率：提供有關主要企業所服務的市場的全面資訊。

2. 市場開發：提供有關利潤豐厚的新興市場的詳細資訊，並分析其在成熟市場的滲透率。

3. 市場多元化：提供有關新產品發布、未開發領域、最新發展和投資的詳細資訊。

4.市場趨勢：全面了解COVID-19、俄羅斯-烏克蘭衝突和高通膨的累積影響。

5.競爭評估與資訊：對主要企業的市場佔有率、策略、產品、認證、法規狀況、專利狀況、製造能力等進行綜合評估。

6. 產品開發與創新：提供對未來技術、研發活動和突破性產品開發的見解。

本報告回答了以下問題：

1. 發作性睡病治療藥物的全球市場規模和預測是多少？

2.在預測期內，COVID-19 對全球發作性睡病治療藥物市場的阻礙因素和影響為何？

3.在預測期內，全球發作性睡病治療藥物市場需要投資哪些產品/細分市場/用途/領域？

4.全球發作性睡病藥物市場的競爭策略為何？

5. 全球發作性睡病藥物市場的技術趨勢和法律規範是什麼？

6.全球發作性睡病治療藥物市場主要供應商的市佔率是多少？

7. 哪些型態和策略性措施可能適合進入發作性睡病藥物全球市場？

目錄

第1章 前言

第2章 調查方法

第3章 執行摘要

第4章 市場概況

第5章 市場洞察

  • 市場動態
    • 促進因素
      • 睡眠障礙發作性睡病的病例正在增加
      • 提高消費者對發作性睡病藥物的認知
      • 政府對發作性睡病治療的核准增加
    • 抑制因素
      • 發作性睡病藥物的不良反應
    • 機會
      • 與發作性睡病治療相關的研究活動增加
      • 優惠報銷政策的出現
    • 任務
      • 醫護人員短缺
  • 市場趨勢
  • COVID-19 的累積影響
  • 俄羅斯-烏克蘭衝突的累積影響
  • 高通膨的累積效應
  • 波特五力分析
  • 價值鍊和關鍵路徑分析
  • 法律規範
  • 客戶客製化

第6章 發作性睡病治療藥物市場：依藥物類別

  • 介紹
  • 中樞神經系統興奮劑
  • 去除劑
  • 血清素再攝取抑制劑
  • 血管升壓藥

第7章 發作性睡病治療藥物市場：依發作性睡病類型

  • 介紹
  • 發作性睡病 1 型
  • 發作性睡病2型

第8章 發作性睡病治療藥物市場：按配銷通路

  • 介紹
  • 藥局
  • 電子商務
  • 零售藥房

第9章 美洲發作性睡病治療藥物市場

  • 介紹
  • 阿根廷
  • 巴西
  • 加拿大
  • 墨西哥
  • 美國

第10章 亞太地區發作性睡病治療藥物市場

  • 介紹
  • 澳洲
  • 中國
  • 印度
  • 印尼
  • 日本
  • 馬來西亞
  • 菲律賓
  • 新加坡
  • 韓國
  • 台灣
  • 泰國
  • 越南

第11章歐洲、中東和非洲發作性睡病治療市場

  • 介紹
  • 丹麥
  • 埃及
  • 芬蘭
  • 法國
  • 德國
  • 以色列
  • 義大利
  • 荷蘭
  • 奈及利亞
  • 挪威
  • 波蘭
  • 卡達
  • 俄羅斯
  • 沙烏地阿拉伯
  • 南非
  • 西班牙
  • 瑞典
  • 瑞士
  • 土耳其
  • 阿拉伯聯合大公國
  • 英國

第12章競爭形勢

  • FPNV定位矩陣
  • 市佔率分析：主要企業
  • 競爭情境分析：主要企業

第13章上市公司名單

第14章附錄

  • 討論指南
  • 關於許可證和定價
Product Code: MRR-036C5CF3B44A

The Global Narcolepsy Treatment Market is forecasted to grow significantly, with a projected USD 3,868.74 million in 2023 at a CAGR of 13.43% and expected to reach a staggering USD 9,361.51 million by 2030.

The Cumulative Impact of COVID-19, the Russia-Ukraine Conflict, and High Inflation is expected to have significant long-term effects on the Global Narcolepsy Treatment Market. The ongoing research considers the changes in consumer behavior, supply chain disruptions, and government interventions caused by the pandemic. Similarly, the report considers the ongoing political and economic uncertainty in Eastern Europe caused by the Russia-Ukraine Conflict and its potential implications for demand-supply balances, pressure on pricing variants, and import/export and trading. Additionally, the report addresses the impact of High Inflation on the global economy and details fiscal policies measuring and reducing its effects on demand, supply, cash flow, and currency exchange.

Market Segmentation & Coverage:

This research report categorizes the Global Narcolepsy Treatment Market in order to forecast the revenues and analyze trends in each of following sub-markets:

Based on Drug Class, market is studied across CNS Stimulants, Decongestants, Serotonin Reuptake Inhibitors, and Vasopressors. The Decongestants is projected to witness significant market share during forecast period.

Based on Narcolepsy Type, market is studied across Narcolepsy Type 1 and Narcolepsy Type 2. The Narcolepsy Type 2 is projected to witness significant market share during forecast period.

Based on Distribution Channel, market is studied across Drug Stores, E-commerce, and Retail Pharmacies. The E-commerce is projected to witness significant market share during forecast period.

Based on Region, market is studied across Americas, Asia-Pacific, and Europe, Middle East & Africa. The Americas is further studied across Argentina, Brazil, Canada, Mexico, and United States. The United States is further studied across California, Florida, Illinois, New York, Ohio, Pennsylvania, and Texas. The Asia-Pacific is further studied across Australia, China, India, Indonesia, Japan, Malaysia, Philippines, Singapore, South Korea, Taiwan, Thailand, and Vietnam. The Europe, Middle East & Africa is further studied across Denmark, Egypt, Finland, France, Germany, Israel, Italy, Netherlands, Nigeria, Norway, Poland, Qatar, Russia, Saudi Arabia, South Africa, Spain, Sweden, Switzerland, Turkey, United Arab Emirates, and United Kingdom. The Americas commanded largest market share of 38.75% in 2022, followed by Europe, Middle East & Africa.

Market Statistics:

The report provides market sizing and forecasts across 7 major currencies - USD, EUR, JPY, GBP, AUD, CAD, and CHF; multiple currency support helps organization leaders to make well-informed decisions. In this report, 2018 to 2021 are considered as historical years, 2022 is base year, 2023 is estimated year, and years from 2024 to 2030 are considered as forecast period.

FPNV Positioning Matrix:

The FPNV Positioning Matrix is essential for assessing the Global Narcolepsy Treatment Market. It provides a comprehensive evaluation of vendors by examining key metrics within Business Strategy and Product Satisfaction, allowing users to make informed decisions based on their specific needs. This advanced analysis then organizes these vendors into four distinct quadrants, which represent varying levels of success: Forefront (F), Pathfinder (P), Niche (N), or Vital(V).

Market Share Analysis:

The Market Share Analysis offers an insightful look at the current state of vendors in a particular market space. By comparing vendor contributions to overall revenue, customer base, and other key metrics, we can give companies a greater understanding of their performance and what they are up against when competing for market share. The analysis also sheds light on just how competitive any given sector is about accumulation, fragmentation dominance, and amalgamation traits over the base year period studied.

The report provides insights on the following pointers:

1. Market Penetration: Provides comprehensive information on the market offered by the key players

2. Market Development: Provides in-depth information about lucrative emerging markets and analyzes penetration across mature segments of the markets

3. Market Diversification: Provides detailed information about new product launches, untapped geographies, recent developments, and investments

4. Market Trends: Provides comprehensive understanding of the Cumulative Impact of COVID-19, the Russia-Ukraine Conflict, and the High Inflation

5. Competitive Assessment & Intelligence: Provides an exhaustive assessment of market shares, strategies, products, certification, regulatory approvals, patent landscape, and manufacturing capabilities of the leading players

6. Product Development & Innovation: Provides intelligent insights on future technologies, R&D activities, and breakthrough product developments

The report answers questions such as:

1. What is the market size and forecast of the Global Narcolepsy Treatment Market?

2. What are the inhibiting factors and impact of COVID-19 shaping the Global Narcolepsy Treatment Market during the forecast period?

3. Which are the products/segments/applications/areas to invest in over the forecast period in the Global Narcolepsy Treatment Market?

4. What is the competitive strategic window for opportunities in the Global Narcolepsy Treatment Market?

5. What are the technology trends and regulatory frameworks in the Global Narcolepsy Treatment Market?

6. What is the market share of the leading vendors in the Global Narcolepsy Treatment Market?

7. What modes and strategic moves are considered suitable for entering the Global Narcolepsy Treatment Market?

Table of Contents

1. Preface

  • 1.1. Objectives of the Study
  • 1.2. Market Segmentation & Coverage
  • 1.3. Years Considered for the Study
  • 1.4. Currency & Pricing
  • 1.5. Language
  • 1.6. Limitations
  • 1.7. Assumptions
  • 1.8. Stakeholders

2. Research Methodology

  • 2.1. Define: Research Objective
  • 2.2. Determine: Research Design
  • 2.3. Prepare: Research Instrument
  • 2.4. Collect: Data Source
  • 2.5. Analyze: Data Interpretation
  • 2.6. Formulate: Data Verification
  • 2.7. Publish: Research Report
  • 2.8. Repeat: Report Update

3. Executive Summary

4. Market Overview

  • 4.1. Introduction
  • 4.2. Narcolepsy Treatment Market, by Drug Class, 2022 vs 2030
  • 4.3. Narcolepsy Treatment Market, by Narcolepsy Type, 2022 vs 2030
  • 4.4. Narcolepsy Treatment Market, by Distribution Channel, 2022 vs 2030
  • 4.5. Narcolepsy Treatment Market, by Region, 2022 vs 2030

5. Market Insights

  • 5.1. Market Dynamics
    • 5.1.1. Drivers
      • 5.1.1.1. Increasing cases of sleep disorder narcolepsy
      • 5.1.1.2. Growing consumer awareness regarding narcolepsy treatment
      • 5.1.1.3. Rising government approvals for narcolepsy therapeutics
    • 5.1.2. Restraints
      • 5.1.2.1. Adverse effects of the narcolepsy treatment
    • 5.1.3. Opportunities
      • 5.1.3.1. Rise in the research activities related to the narcolepsy treatment
      • 5.1.3.2. Emergence of favorable reimbursement policies
    • 5.1.4. Challenges
      • 5.1.4.1. Shortage of medical professionals
  • 5.2. Market Trends
  • 5.3. Cumulative Impact of COVID-19
  • 5.4. Cumulative Impact of Russia-Ukraine Conflict
  • 5.5. Cumulative Impact of High Inflation
  • 5.6. Porter's Five Forces Analysis
    • 5.6.1. Threat of New Entrants
    • 5.6.2. Threat of Substitutes
    • 5.6.3. Bargaining Power of Customers
    • 5.6.4. Bargaining Power of Suppliers
    • 5.6.5. Industry Rivalry
  • 5.7. Value Chain & Critical Path Analysis
  • 5.8. Regulatory Framework
  • 5.9. Client Customization

6. Narcolepsy Treatment Market, by Drug Class

  • 6.1. Introduction
  • 6.2. CNS Stimulants
  • 6.3. Decongestants
  • 6.4. Serotonin Reuptake Inhibitors
  • 6.5. Vasopressors

7. Narcolepsy Treatment Market, by Narcolepsy Type

  • 7.1. Introduction
  • 7.2. Narcolepsy Type 1
  • 7.3. Narcolepsy Type 2

8. Narcolepsy Treatment Market, by Distribution Channel

  • 8.1. Introduction
  • 8.2. Drug Stores
  • 8.3. E-commerce
  • 8.4. Retail Pharmacies

9. Americas Narcolepsy Treatment Market

  • 9.1. Introduction
  • 9.2. Argentina
  • 9.3. Brazil
  • 9.4. Canada
  • 9.5. Mexico
  • 9.6. United States

10. Asia-Pacific Narcolepsy Treatment Market

  • 10.1. Introduction
  • 10.2. Australia
  • 10.3. China
  • 10.4. India
  • 10.5. Indonesia
  • 10.6. Japan
  • 10.7. Malaysia
  • 10.8. Philippines
  • 10.9. Singapore
  • 10.10. South Korea
  • 10.11. Taiwan
  • 10.12. Thailand
  • 10.13. Vietnam

11. Europe, Middle East & Africa Narcolepsy Treatment Market

  • 11.1. Introduction
  • 11.2. Denmark
  • 11.3. Egypt
  • 11.4. Finland
  • 11.5. France
  • 11.6. Germany
  • 11.7. Israel
  • 11.8. Italy
  • 11.9. Netherlands
  • 11.10. Nigeria
  • 11.11. Norway
  • 11.12. Poland
  • 11.13. Qatar
  • 11.14. Russia
  • 11.15. Saudi Arabia
  • 11.16. South Africa
  • 11.17. Spain
  • 11.18. Sweden
  • 11.19. Switzerland
  • 11.20. Turkey
  • 11.21. United Arab Emirates
  • 11.22. United Kingdom

12. Competitive Landscape

  • 12.1. FPNV Positioning Matrix
  • 12.2. Market Share Analysis, By Key Player
  • 12.3. Competitive Scenario Analysis, By Key Player

13. List of Company Mentioned

14. Appendix

  • 14.1. Discussion Guide
  • 14.2. License & Pricing

LIST OF FIGURES

  • FIGURE 1. NARCOLEPSY TREATMENT MARKET RESEARCH PROCESS
  • FIGURE 2. NARCOLEPSY TREATMENT MARKET SIZE, 2022 VS 2030
  • FIGURE 3. NARCOLEPSY TREATMENT MARKET SIZE, 2018-2030 (USD MILLION)
  • FIGURE 4. NARCOLEPSY TREATMENT MARKET SIZE, BY DRUG CLASS, 2022 VS 2030 (%)
  • FIGURE 5. NARCOLEPSY TREATMENT MARKET SIZE, BY NARCOLEPSY TYPE, 2022 VS 2030 (%)
  • FIGURE 6. NARCOLEPSY TREATMENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2022 VS 2030 (%)
  • FIGURE 7. NARCOLEPSY TREATMENT MARKET SIZE, BY REGION, 2022 VS 2030 (%)
  • FIGURE 8. NARCOLEPSY TREATMENT MARKET DYNAMICS
  • FIGURE 9. NARCOLEPSY TREATMENT MARKET SIZE, BY DRUG CLASS, 2022 VS 2023 VS 2030 (USD MILLION)
  • FIGURE 10. NARCOLEPSY TREATMENT MARKET SIZE, BY NARCOLEPSY TYPE, 2022 VS 2023 VS 2030 (USD MILLION)
  • FIGURE 11. NARCOLEPSY TREATMENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2022 VS 2023 VS 2030 (USD MILLION)
  • FIGURE 12. AMERICAS NARCOLEPSY TREATMENT MARKET SIZE, BY COUNTRY, 2022 VS 2023 VS 2030 (USD MILLION)
  • FIGURE 13. UNITED STATES NARCOLEPSY TREATMENT MARKET SIZE, BY STATE, 2022 VS 2023 VS 2030 (USD MILLION)
  • FIGURE 14. ASIA-PACIFIC NARCOLEPSY TREATMENT MARKET SIZE, BY COUNTRY, 2022 VS 2023 VS 2030 (USD MILLION)
  • FIGURE 15. EUROPE, MIDDLE EAST & AFRICA NARCOLEPSY TREATMENT MARKET SIZE, BY COUNTRY, 2022 VS 2023 VS 2030 (USD MILLION)
  • FIGURE 16. NARCOLEPSY TREATMENT MARKET, FPNV POSITIONING MATRIX, 2022
  • FIGURE 17. NARCOLEPSY TREATMENT MARKET SHARE, BY KEY PLAYER, 2022

LIST OF TABLES

  • TABLE 1. NARCOLEPSY TREATMENT MARKET SEGMENTATION & COVERAGE
  • TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2022
  • TABLE 3. NARCOLEPSY TREATMENT MARKET SIZE, 2018-2030 (USD MILLION)
  • TABLE 4. NARCOLEPSY TREATMENT MARKET SIZE, BY DRUG CLASS, 2018-2030 (USD MILLION)
  • TABLE 5. NARCOLEPSY TREATMENT MARKET SIZE, BY CNS STIMULANTS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 6. NARCOLEPSY TREATMENT MARKET SIZE, BY DECONGESTANTS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 7. NARCOLEPSY TREATMENT MARKET SIZE, BY SEROTONIN REUPTAKE INHIBITORS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 8. NARCOLEPSY TREATMENT MARKET SIZE, BY VASOPRESSORS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 9. NARCOLEPSY TREATMENT MARKET SIZE, BY NARCOLEPSY TYPE, 2018-2030 (USD MILLION)
  • TABLE 10. NARCOLEPSY TREATMENT MARKET SIZE, BY NARCOLEPSY TYPE 1, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 11. NARCOLEPSY TREATMENT MARKET SIZE, BY NARCOLEPSY TYPE 2, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 12. NARCOLEPSY TREATMENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 13. NARCOLEPSY TREATMENT MARKET SIZE, BY DRUG STORES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 14. NARCOLEPSY TREATMENT MARKET SIZE, BY E-COMMERCE, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 15. NARCOLEPSY TREATMENT MARKET SIZE, BY RETAIL PHARMACIES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 16. AMERICAS NARCOLEPSY TREATMENT MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 17. AMERICAS NARCOLEPSY TREATMENT MARKET SIZE, BY DRUG CLASS, 2018-2030 (USD MILLION)
  • TABLE 18. AMERICAS NARCOLEPSY TREATMENT MARKET SIZE, BY NARCOLEPSY TYPE, 2018-2030 (USD MILLION)
  • TABLE 19. AMERICAS NARCOLEPSY TREATMENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 20. ARGENTINA NARCOLEPSY TREATMENT MARKET SIZE, BY DRUG CLASS, 2018-2030 (USD MILLION)
  • TABLE 21. ARGENTINA NARCOLEPSY TREATMENT MARKET SIZE, BY NARCOLEPSY TYPE, 2018-2030 (USD MILLION)
  • TABLE 22. ARGENTINA NARCOLEPSY TREATMENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 23. BRAZIL NARCOLEPSY TREATMENT MARKET SIZE, BY DRUG CLASS, 2018-2030 (USD MILLION)
  • TABLE 24. BRAZIL NARCOLEPSY TREATMENT MARKET SIZE, BY NARCOLEPSY TYPE, 2018-2030 (USD MILLION)
  • TABLE 25. BRAZIL NARCOLEPSY TREATMENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 26. CANADA NARCOLEPSY TREATMENT MARKET SIZE, BY DRUG CLASS, 2018-2030 (USD MILLION)
  • TABLE 27. CANADA NARCOLEPSY TREATMENT MARKET SIZE, BY NARCOLEPSY TYPE, 2018-2030 (USD MILLION)
  • TABLE 28. CANADA NARCOLEPSY TREATMENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 29. MEXICO NARCOLEPSY TREATMENT MARKET SIZE, BY DRUG CLASS, 2018-2030 (USD MILLION)
  • TABLE 30. MEXICO NARCOLEPSY TREATMENT MARKET SIZE, BY NARCOLEPSY TYPE, 2018-2030 (USD MILLION)
  • TABLE 31. MEXICO NARCOLEPSY TREATMENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 32. UNITED STATES NARCOLEPSY TREATMENT MARKET SIZE, BY STATE, 2018-2030 (USD MILLION)
  • TABLE 33. UNITED STATES NARCOLEPSY TREATMENT MARKET SIZE, BY DRUG CLASS, 2018-2030 (USD MILLION)
  • TABLE 34. UNITED STATES NARCOLEPSY TREATMENT MARKET SIZE, BY NARCOLEPSY TYPE, 2018-2030 (USD MILLION)
  • TABLE 35. UNITED STATES NARCOLEPSY TREATMENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 36. ASIA-PACIFIC NARCOLEPSY TREATMENT MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 37. ASIA-PACIFIC NARCOLEPSY TREATMENT MARKET SIZE, BY DRUG CLASS, 2018-2030 (USD MILLION)
  • TABLE 38. ASIA-PACIFIC NARCOLEPSY TREATMENT MARKET SIZE, BY NARCOLEPSY TYPE, 2018-2030 (USD MILLION)
  • TABLE 39. ASIA-PACIFIC NARCOLEPSY TREATMENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 40. AUSTRALIA NARCOLEPSY TREATMENT MARKET SIZE, BY DRUG CLASS, 2018-2030 (USD MILLION)
  • TABLE 41. AUSTRALIA NARCOLEPSY TREATMENT MARKET SIZE, BY NARCOLEPSY TYPE, 2018-2030 (USD MILLION)
  • TABLE 42. AUSTRALIA NARCOLEPSY TREATMENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 43. CHINA NARCOLEPSY TREATMENT MARKET SIZE, BY DRUG CLASS, 2018-2030 (USD MILLION)
  • TABLE 44. CHINA NARCOLEPSY TREATMENT MARKET SIZE, BY NARCOLEPSY TYPE, 2018-2030 (USD MILLION)
  • TABLE 45. CHINA NARCOLEPSY TREATMENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 46. INDIA NARCOLEPSY TREATMENT MARKET SIZE, BY DRUG CLASS, 2018-2030 (USD MILLION)
  • TABLE 47. INDIA NARCOLEPSY TREATMENT MARKET SIZE, BY NARCOLEPSY TYPE, 2018-2030 (USD MILLION)
  • TABLE 48. INDIA NARCOLEPSY TREATMENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 49. INDONESIA NARCOLEPSY TREATMENT MARKET SIZE, BY DRUG CLASS, 2018-2030 (USD MILLION)
  • TABLE 50. INDONESIA NARCOLEPSY TREATMENT MARKET SIZE, BY NARCOLEPSY TYPE, 2018-2030 (USD MILLION)
  • TABLE 51. INDONESIA NARCOLEPSY TREATMENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 52. JAPAN NARCOLEPSY TREATMENT MARKET SIZE, BY DRUG CLASS, 2018-2030 (USD MILLION)
  • TABLE 53. JAPAN NARCOLEPSY TREATMENT MARKET SIZE, BY NARCOLEPSY TYPE, 2018-2030 (USD MILLION)
  • TABLE 54. JAPAN NARCOLEPSY TREATMENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 55. MALAYSIA NARCOLEPSY TREATMENT MARKET SIZE, BY DRUG CLASS, 2018-2030 (USD MILLION)
  • TABLE 56. MALAYSIA NARCOLEPSY TREATMENT MARKET SIZE, BY NARCOLEPSY TYPE, 2018-2030 (USD MILLION)
  • TABLE 57. MALAYSIA NARCOLEPSY TREATMENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 58. PHILIPPINES NARCOLEPSY TREATMENT MARKET SIZE, BY DRUG CLASS, 2018-2030 (USD MILLION)
  • TABLE 59. PHILIPPINES NARCOLEPSY TREATMENT MARKET SIZE, BY NARCOLEPSY TYPE, 2018-2030 (USD MILLION)
  • TABLE 60. PHILIPPINES NARCOLEPSY TREATMENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 61. SINGAPORE NARCOLEPSY TREATMENT MARKET SIZE, BY DRUG CLASS, 2018-2030 (USD MILLION)
  • TABLE 62. SINGAPORE NARCOLEPSY TREATMENT MARKET SIZE, BY NARCOLEPSY TYPE, 2018-2030 (USD MILLION)
  • TABLE 63. SINGAPORE NARCOLEPSY TREATMENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 64. SOUTH KOREA NARCOLEPSY TREATMENT MARKET SIZE, BY DRUG CLASS, 2018-2030 (USD MILLION)
  • TABLE 65. SOUTH KOREA NARCOLEPSY TREATMENT MARKET SIZE, BY NARCOLEPSY TYPE, 2018-2030 (USD MILLION)
  • TABLE 66. SOUTH KOREA NARCOLEPSY TREATMENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 67. TAIWAN NARCOLEPSY TREATMENT MARKET SIZE, BY DRUG CLASS, 2018-2030 (USD MILLION)
  • TABLE 68. TAIWAN NARCOLEPSY TREATMENT MARKET SIZE, BY NARCOLEPSY TYPE, 2018-2030 (USD MILLION)
  • TABLE 69. TAIWAN NARCOLEPSY TREATMENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 70. THAILAND NARCOLEPSY TREATMENT MARKET SIZE, BY DRUG CLASS, 2018-2030 (USD MILLION)
  • TABLE 71. THAILAND NARCOLEPSY TREATMENT MARKET SIZE, BY NARCOLEPSY TYPE, 2018-2030 (USD MILLION)
  • TABLE 72. THAILAND NARCOLEPSY TREATMENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 73. VIETNAM NARCOLEPSY TREATMENT MARKET SIZE, BY DRUG CLASS, 2018-2030 (USD MILLION)
  • TABLE 74. VIETNAM NARCOLEPSY TREATMENT MARKET SIZE, BY NARCOLEPSY TYPE, 2018-2030 (USD MILLION)
  • TABLE 75. VIETNAM NARCOLEPSY TREATMENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 76. EUROPE, MIDDLE EAST & AFRICA NARCOLEPSY TREATMENT MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 77. EUROPE, MIDDLE EAST & AFRICA NARCOLEPSY TREATMENT MARKET SIZE, BY DRUG CLASS, 2018-2030 (USD MILLION)
  • TABLE 78. EUROPE, MIDDLE EAST & AFRICA NARCOLEPSY TREATMENT MARKET SIZE, BY NARCOLEPSY TYPE, 2018-2030 (USD MILLION)
  • TABLE 79. EUROPE, MIDDLE EAST & AFRICA NARCOLEPSY TREATMENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 80. DENMARK NARCOLEPSY TREATMENT MARKET SIZE, BY DRUG CLASS, 2018-2030 (USD MILLION)
  • TABLE 81. DENMARK NARCOLEPSY TREATMENT MARKET SIZE, BY NARCOLEPSY TYPE, 2018-2030 (USD MILLION)
  • TABLE 82. DENMARK NARCOLEPSY TREATMENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 83. EGYPT NARCOLEPSY TREATMENT MARKET SIZE, BY DRUG CLASS, 2018-2030 (USD MILLION)
  • TABLE 84. EGYPT NARCOLEPSY TREATMENT MARKET SIZE, BY NARCOLEPSY TYPE, 2018-2030 (USD MILLION)
  • TABLE 85. EGYPT NARCOLEPSY TREATMENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 86. FINLAND NARCOLEPSY TREATMENT MARKET SIZE, BY DRUG CLASS, 2018-2030 (USD MILLION)
  • TABLE 87. FINLAND NARCOLEPSY TREATMENT MARKET SIZE, BY NARCOLEPSY TYPE, 2018-2030 (USD MILLION)
  • TABLE 88. FINLAND NARCOLEPSY TREATMENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 89. FRANCE NARCOLEPSY TREATMENT MARKET SIZE, BY DRUG CLASS, 2018-2030 (USD MILLION)
  • TABLE 90. FRANCE NARCOLEPSY TREATMENT MARKET SIZE, BY NARCOLEPSY TYPE, 2018-2030 (USD MILLION)
  • TABLE 91. FRANCE NARCOLEPSY TREATMENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 92. GERMANY NARCOLEPSY TREATMENT MARKET SIZE, BY DRUG CLASS, 2018-2030 (USD MILLION)
  • TABLE 93. GERMANY NARCOLEPSY TREATMENT MARKET SIZE, BY NARCOLEPSY TYPE, 2018-2030 (USD MILLION)
  • TABLE 94. GERMANY NARCOLEPSY TREATMENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 95. ISRAEL NARCOLEPSY TREATMENT MARKET SIZE, BY DRUG CLASS, 2018-2030 (USD MILLION)
  • TABLE 96. ISRAEL NARCOLEPSY TREATMENT MARKET SIZE, BY NARCOLEPSY TYPE, 2018-2030 (USD MILLION)
  • TABLE 97. ISRAEL NARCOLEPSY TREATMENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 98. ITALY NARCOLEPSY TREATMENT MARKET SIZE, BY DRUG CLASS, 2018-2030 (USD MILLION)
  • TABLE 99. ITALY NARCOLEPSY TREATMENT MARKET SIZE, BY NARCOLEPSY TYPE, 2018-2030 (USD MILLION)
  • TABLE 100. ITALY NARCOLEPSY TREATMENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 101. NETHERLANDS NARCOLEPSY TREATMENT MARKET SIZE, BY DRUG CLASS, 2018-2030 (USD MILLION)
  • TABLE 102. NETHERLANDS NARCOLEPSY TREATMENT MARKET SIZE, BY NARCOLEPSY TYPE, 2018-2030 (USD MILLION)
  • TABLE 103. NETHERLANDS NARCOLEPSY TREATMENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 104. NIGERIA NARCOLEPSY TREATMENT MARKET SIZE, BY DRUG CLASS, 2018-2030 (USD MILLION)
  • TABLE 105. NIGERIA NARCOLEPSY TREATMENT MARKET SIZE, BY NARCOLEPSY TYPE, 2018-2030 (USD MILLION)
  • TABLE 106. NIGERIA NARCOLEPSY TREATMENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 107. NORWAY NARCOLEPSY TREATMENT MARKET SIZE, BY DRUG CLASS, 2018-2030 (USD MILLION)
  • TABLE 108. NORWAY NARCOLEPSY TREATMENT MARKET SIZE, BY NARCOLEPSY TYPE, 2018-2030 (USD MILLION)
  • TABLE 109. NORWAY NARCOLEPSY TREATMENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 110. POLAND NARCOLEPSY TREATMENT MARKET SIZE, BY DRUG CLASS, 2018-2030 (USD MILLION)
  • TABLE 111. POLAND NARCOLEPSY TREATMENT MARKET SIZE, BY NARCOLEPSY TYPE, 2018-2030 (USD MILLION)
  • TABLE 112. POLAND NARCOLEPSY TREATMENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 113. QATAR NARCOLEPSY TREATMENT MARKET SIZE, BY DRUG CLASS, 2018-2030 (USD MILLION)
  • TABLE 114. QATAR NARCOLEPSY TREATMENT MARKET SIZE, BY NARCOLEPSY TYPE, 2018-2030 (USD MILLION)
  • TABLE 115. QATAR NARCOLEPSY TREATMENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 116. RUSSIA NARCOLEPSY TREATMENT MARKET SIZE, BY DRUG CLASS, 2018-2030 (USD MILLION)
  • TABLE 117. RUSSIA NARCOLEPSY TREATMENT MARKET SIZE, BY NARCOLEPSY TYPE, 2018-2030 (USD MILLION)
  • TABLE 118. RUSSIA NARCOLEPSY TREATMENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 119. SAUDI ARABIA NARCOLEPSY TREATMENT MARKET SIZE, BY DRUG CLASS, 2018-2030 (USD MILLION)
  • TABLE 120. SAUDI ARABIA NARCOLEPSY TREATMENT MARKET SIZE, BY NARCOLEPSY TYPE, 2018-2030 (USD MILLION)
  • TABLE 121. SAUDI ARABIA NARCOLEPSY TREATMENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 122. SOUTH AFRICA NARCOLEPSY TREATMENT MARKET SIZE, BY DRUG CLASS, 2018-2030 (USD MILLION)
  • TABLE 123. SOUTH AFRICA NARCOLEPSY TREATMENT MARKET SIZE, BY NARCOLEPSY TYPE, 2018-2030 (USD MILLION)
  • TABLE 124. SOUTH AFRICA NARCOLEPSY TREATMENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 125. SPAIN NARCOLEPSY TREATMENT MARKET SIZE, BY DRUG CLASS, 2018-2030 (USD MILLION)
  • TABLE 126. SPAIN NARCOLEPSY TREATMENT MARKET SIZE, BY NARCOLEPSY TYPE, 2018-2030 (USD MILLION)
  • TABLE 127. SPAIN NARCOLEPSY TREATMENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 128. SWEDEN NARCOLEPSY TREATMENT MARKET SIZE, BY DRUG CLASS, 2018-2030 (USD MILLION)
  • TABLE 129. SWEDEN NARCOLEPSY TREATMENT MARKET SIZE, BY NARCOLEPSY TYPE, 2018-2030 (USD MILLION)
  • TABLE 130. SWEDEN NARCOLEPSY TREATMENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 131. SWITZERLAND NARCOLEPSY TREATMENT MARKET SIZE, BY DRUG CLASS, 2018-2030 (USD MILLION)
  • TABLE 132. SWITZERLAND NARCOLEPSY TREATMENT MARKET SIZE, BY NARCOLEPSY TYPE, 2018-2030 (USD MILLION)
  • TABLE 133. SWITZERLAND NARCOLEPSY TREATMENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 134. TURKEY NARCOLEPSY TREATMENT MARKET SIZE, BY DRUG CLASS, 2018-2030 (USD MILLION)
  • TABLE 135. TURKEY NARCOLEPSY TREATMENT MARKET SIZE, BY NARCOLEPSY TYPE, 2018-2030 (USD MILLION)
  • TABLE 136. TURKEY NARCOLEPSY TREATMENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 137. UNITED ARAB EMIRATES NARCOLEPSY TREATMENT MARKET SIZE, BY DRUG CLASS, 2018-2030 (USD MILLION)
  • TABLE 138. UNITED ARAB EMIRATES NARCOLEPSY TREATMENT MARKET SIZE, BY NARCOLEPSY TYPE, 2018-2030 (USD MILLION)
  • TABLE 139. UNITED ARAB EMIRATES NARCOLEPSY TREATMENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 140. UNITED KINGDOM NARCOLEPSY TREATMENT MARKET SIZE, BY DRUG CLASS, 2018-2030 (USD MILLION)
  • TABLE 141. UNITED KINGDOM NARCOLEPSY TREATMENT MARKET SIZE, BY NARCOLEPSY TYPE, 2018-2030 (USD MILLION)
  • TABLE 142. UNITED KINGDOM NARCOLEPSY TREATMENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 143. NARCOLEPSY TREATMENT MARKET, FPNV POSITIONING MATRIX, 2022
  • TABLE 144. NARCOLEPSY TREATMENT MARKET SHARE, BY KEY PLAYER, 2022
  • TABLE 145. NARCOLEPSY TREATMENT MARKET LICENSE & PRICING